Skip to main content
. 2015 Apr 22;9:48. doi: 10.3389/fnana.2015.00048

FIGURE 8.

FIGURE 8

2, 4-diamino-6-hydroxypyrimidine and TP treatment attenuated the increasing expressions of pERK1/ERK1 and pERK2/ERK2. (A) The expressions of pERK1/ERK1 and pERK2/ERK2 were increased in MCAO group compared to control group. DAHP and TP treatment significantly attenuated the increasing expressions of pERK1/ERK1 (B) and pERK2/ERK2 (C). **P < 0.01 vs. control group; *P < 0.05 vs. control group; #P < 0.05 vs. MCAO group; ##P < 0.01 vs. MCAO group.